Loading…
Reported covered position: MEMBER/HOUSE 1993-2001
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pathway for Biosimilars Act
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness of the research-based biopharmaceutical and medical technology sector Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
Comparative Effectiveness Research Act of 2009
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2010 · first_quarter · Q1
promoting awareness of the research-based biopharmaceutical and medical technology sector Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
promoting awareness of the research-based biopharmaceutical and medical technology sector Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
America's Affordable Health Choices Act of 2009
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness of the research-based biopharmaceutical and medical technology sector Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
Pathway for Biosimilars Act
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act
Pathway for Biosimilars Act
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
Pathway for Biosimilars Act
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Support Eshoo-Barton Pathways to Biosimilars Act HR 1548 Support Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform health care reform- supported open access and choice of plans
Comparative Effectiveness Research Act of 2009
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
America's Affordable Health Choices Act of 2009
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act
America's Affordable Health Choices Act of 2009
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
To amend title 5, United States Code, to increase the level of Government contributions under the Federal employees health benefits program.
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
Supporting legislation to regulate tobacco products through the FDA-opposing amendments to important prescription drugs HR 1256
Quinebaug and Shetucket Rivers Valley National Heritage Corridor Amendments Act of 2007
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
S 1182 Patent Reform Act
Medicare Prescription Drug Price Negotiation Act of 2007
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
* HR 4 S.3 Medicare Non-Interference FDA Reform Legislation Medical Device User Fees Prescription Drug User Fees REMS SCHIP Children's Health Insurance Legislation
Department of Homeland Security Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Department of Homeland Security Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Department of Homeland Security Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Medicare Prescription Drug Price Negotiation Act of 2007
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
* HR 4 S.3 Medicare Non-Interference FDA Reform Legislation Medical Device User Fees Prescription Drug User Fees REMS SCHIP Children's Health Insurance Legislation
Small Business Expensing Permanency Act of 2003
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Small Business Expensing Permanency Act of 2003
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Small Business Expensing Permanency Act of 2003
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: HEALTHCARE INSTITUTE OF NEW JERSEY · Firm: HEALTHCARE INSTITUTE OF NEW JERSEY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2009 · fourth_quarter · Q4
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act HR 2502 Comparative Effectiveness Research Act of 2009
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2009 · third_quarter · Q3
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Eshoo-Barton Pathways to Biosimilars Act HR 1548 Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform America's Affordable Health Choices Act HR.3200 America's Healthy Future Act
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2009 · second_quarter · Q2
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey Support Eshoo-Barton Pathways to Biosimilars Act HR 1548 Support Kennedy Pathways to Biosimilars Act Chronic disease prevention and treatment incentives in health care reform health care reform- supported open access and choice of plans
Supporting legislation to regulate tobacco products through the FDA-opposing amendments to important prescription drugs HR 1256
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2009 · first_quarter · Q1
Oppose Medical Device Safety Act of 2009
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Support Eshoo/Barton Pathways to Biosimilars Act Support Kennedy Pathways to Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2008 · fourth_quarter · Q4
Oppose the Medical Device Safety Act of 2008
Promoting understanding of the causes and cost of chronic disease.
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2008 · fourth_quarter · RA
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2008 · third_quarter · Q3
Promoting understanding of the causes and cost of chronic disease.
Oppose the Medical Device Safety Act of 2008
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2008 · second_quarter · Q2
Advocating for patent protections in trade bills and in foreign government operations
Advocating on behalf of Medicare Part D open access and encouraging open market access to medications
recognizing the importance of biomedical research, diagnostics, and technologies.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2008 · first_quarter · Q1
Medicare Reform Package
FY09 Agriculture Appropriations and FY09 Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To promote the better understanding of the pharmaceutical and medical device industry in New Jersey.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2007 · year_end · YY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To promote understanding of issues around the research based biopharmaceutical and medical device industry
To promote intellectual property protection in all trade agreements- in particular Andean Trade, Thailand, and Brazil.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2007 · year_end · YY
To promote understanding of issues around the research based biopharmaceutical and medical device industry
To promote Medicare Modernization Act and educate members about the program and its success.
To promote intellectual property protection in all trade agreements- in particular Andean Trade, Thailand, and Brazil.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2007 · year_end · YY
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
To promote Medicare Modernization Act and educate members about the program and its success.
To promote intellectual property protection in all trade agreements- in particular Andean Trade, Thailand, and Brazil.
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2007 · mid_year · MM
* HR 4 S.3 Medicare Non-Interference FDA Reform Legislation Medical Device User Fees Prescription Drug User Fees REMS SCHIP Children's Health Insurance Legislation
Prescription Drug Imporation/Agricultural Appropriations Legislation
House and Senate Patent Reform Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2006 · year_end · YY
Agricultural Appropriations-FDA Reimportation
* Medicare Part D implementation Regulating the Reprocessing of Single-Use Medical Devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2006 · mid_year · RA
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2004 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2003 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2003 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2002 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2002 · year_end · RA
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2002 · year_end · RA
HEALTHCARE INSTITUTE OF NEW JERSEY via HEALTHCARE INSTITUTE OF NEW JERSEY
2002 · mid_year · RR
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
importation in appropriations bills, patent reform, health care reform, pharmaceutcial and medical device pricing, reimbursement issues, Medicare Part D coverage and pricing, corporate tax, trade agreeements, preemption.
Opposing House and Senate Patent Reform of 2008 Legislation.
promoting awareness and advocacy of the biopharmaceutical and medical technology industry in New Jersey
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to importation of prescription drugs and intellectual property protections.
S 1182 Patent Reform Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
To promote Medicare Modernization Act and educate members about the program and its success.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3161; S. 1859-Agriculture Appropriations and H.R. 2638; S.1644-Homeland Security Appropriations related to proposals limiting FDA authority to regulate pharmaceutical imports
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
To promote understanding of issues around the research based biopharmaceutical and medical device industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE